TLIS Talis Biomedical Corporation: Multiplikator Forward P/S

Logo grafis Talis Biomedical (TLIS)

Talis Biomedical revenues are based on rapid tests and the implementation of the Talis One system for clinics. The projected P/S metric visualizes market confidence in these sales, where 26.60 determines the current status of the parameter. Efficiency is supported by contract electronics manufacturing and third-party logistics. Independence from macroeconomic trends and the demand for innovation transform the company into a resilient defensive asset.

Talis Biomedical Corporation - Rasio kapitalisasi marang dodolan sing dikarepake TLIS (periode 04.07.2022 - 07.09.2024)

Rincian metrik lan analitis perusahaan talis.bio (TLIS)

- rega saiki lan proyeksi nilai saham:
Rega saham Talis Biomedical Corporation|TLIS - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar Talis Biomedical Corporation|TLIS - Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham Talis Biomedical|TLIS - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku talis.bio|TLIS - Gunggung Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Talis Biomedical|TLIS - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Talis Biomedical Corporation|TLIS - Utang perusahaan|Utang marang nilai buku Talis Biomedical Corporation|TLIS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Talis Biomedical|Likuiditas cepet talis.bio
- rincian asil keuangan lan kelipatan valuasi:
TLIS - Bathi resik taunan|Bathi mangsa ngarep Talis Biomedical|TLIS - Pangali P/E|Pangali Forward P/E Talis Biomedical Corporation|TLIS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Talis Biomedical Corporation|TLIS - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Talis Biomedical|TLIS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan talis.bio|TLIS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Talis Biomedical
- indikator volume dodolan lan pendapatan:
TLIS - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Talis Biomedical Corporation|TLIS - Kapitalisasi marang volume dodolan|Multiplikator forward rega marang pendapatan Talis Biomedical Corporation
Ringkesan analitik perusahaan:Talis Biomedical Corp (TLIS)
Sampel barang Talis Biomedical Corporation

Talis Biomedical (TLIS) possesses high R&D potential in the development of the Talis One cloud platform, positioning the company as a technological innovator in the rapid diagnostics sector. An analysis of the forward P/S ratio allows for an assessment of the company's market value relative to expected revenue, where a compression of this multiple signals a shift in the macroeconomic cycle and the correlation of shares with other assets, helping investors rebalance capital in a timely manner.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Semler (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network, Inc. BFLY|mesalabs.com - Rasio rega marang prakiraan pendapatan|QSI: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NNOX (Nano-X Imaging)|QTRX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep 908 Devices Corporation (MASS)|Rasio rega marang prakiraan pendapatan CapsoVision, Inc.|MXCT - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan RPID (Rapid Micro Biosystems)|Multiplikator Forward P/S Seer Inc (SEER)|Multiplikator Forward P/S HYPR (Hyperfine Corp)|Rasio kapitalisasi marang dodolan sing dikarepake FONAR Corporation Inc (FONR)|DXR - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan MDAI|VivoSim Labs Inc (VIVS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Aclarion Inc|AKYA (Akoya Biosciences Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cesca Therapeutics THMO|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)